Magnesium Research


Is magnesium deficit in lymphocytes a part of the mitral valve prolapse syndrome? Volume 17, issue 1, March 2004


See all figures

Department of Cardiology, University of Lund, Malmö University Hospital MAS, Malmö, Sweden; Department of Coronary Disease, Jagiellonian University, Cracow, Poland; Radioligand Laboratory, Faculty of Pharmacology, Jagiellonian University, Cracow, Poland

Magnesium deficiency has been proposed to be related to the mitral valve prolapse syndrome. However determinations of magnesium concentration in blood serum and hemolysates of red blood cells in this disease revealed divergent results. We investigated 49 patients with the mitral valve prolapse syndrome and 30 healthy individuals, matched by age and gender. The concentration of magnesium was measured in blood plasma and lysates of lymphocytes isolated from venous blood. The magnesium concentration in plasma was similar in both the patients and the healthy controls. By contrast, the magnesium concentration in lysates of lymphocytes was significantly lower (p < 0.03) in the patients with mitral valve prolapse syndrome than in the controls (range: 1.94‐10.6 mmol\g of protein in Lymphocyte lysate; median 5.98 and 6.7‐9.61 mmol\g of protein; median 7.22). The results obtained suggest that magnesium deficiency may be part of the mechanisms of the mitral valve prolapse syndrome.